Ibrutinib as a monotherapy for relapsed or refractory DLBCL patients: a single-center experience. (October 2019)

Record Type:: Journal Article
Title:: Ibrutinib as a monotherapy for relapsed or refractory DLBCL patients: a single-center experience. (October 2019)
Main Title:: Ibrutinib as a monotherapy for relapsed or refractory DLBCL patients: a single-center experience
Authors:: Ekinci, O.
Merter, M.
Abstract:
Is Part Of:: Leukemia research. Volume 85(2019)Supplement 1
Journal:: Leukemia research
Issue:: Volume 85(2019)Supplement 1
Issue Display:: Volume 85, Issue 1 (2019)
Year:: 2019
Volume:: 85
Issue:: 1
Issue Sort Value:: 2019-0085-0001-0000
Page Start:: S55
Page End:
Publication Date:: 2019-10
Subjects:: Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:: http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0145-2126(19)30337-6 ↗
Languages:: English
ISSNs:: 0145-2126
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12049.xml